PREVALENSI HIPERURISEMIA PADA PENDERITA PENYAKIT GINJAL KRONIK STADIUM 1-5 NON DIALISIS DI POLIKLINIK GINJAL-HIPERTENSI RSUD Dr. SOETOMO SURABAYA PERIODE SEPTEMBER - NOVEMBER 2016

• Main Author: Aldira Rasthy Krisdania, NIM011311133218
• Format: Theses and Dissertations NonPeerReviewed
• Language: Indonesian; Indonesian
• Published: 2017
• Subjects: RC Internal medicine
• Online Access: http://repository.unair.ac.id/66252/1/FK%20PD%2067-17%20Kri%20p%20Abstrak.pdf; http://repository.unair.ac.id/66252/2/FK%20PD%2067-17%20Kri%20p%20Sec.pdf; http://repository.unair.ac.id/66252/; http://lib.unair.ac.id
• Institution: Universitas Airlangga

CKD is kidney damage for ≥ 3 months, as defined by structural or functional abnormalities of the kidney, with or without decreased GFR, or GFR ≤60 ml/min/1.73 m2 for≥3 months, with or without kidney damage. Hyperuricaemia is often associated with CKD because the main excretion of uric acid is through the kidneys. Hyperuricaemia may be risk factors that accelerate the progression of CKD Objective: This research aims to study the prevalence of hyperuricemia in non-dialysis CKD in order to improve services for patients. Method: This was a retrospective study by assessing patients’ medical record and analyzed descriptively. Result: Of 73 samples, the majority of CKD patients are male (54,8%) and most are found in 35-60 years old age group. Non-dialysis CKD patients are mostly in stage G4 (32,9%). Hyperuricaemia is found in 68,49% non-dialysis CKD patients with 7,64 mg/dL as the mean highest uric acid level in stage G2. Mean uric acid levels inter-stage are fluctuating. Of all patients with hyperuricaemia, 88% have a history of Allopurinol treatment and 72% also have hypertension. Conclusion: With the lack of information, it still needs further studies with more time and samples, so the results could be more representative.